418 related articles for article (PubMed ID: 28347243)
1. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.
Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ
Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902
[TBL] [Abstract][Full Text] [Related]
3. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Koh YW; Han JH; Haam S; Jung J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
5. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
6. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Koh YW; Han JH; Haam S
Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
8. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
9. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
11. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.
Ricciardi M; Zanotto M; Malpeli G; Bassi G; Perbellini O; Chilosi M; Bifari F; Krampera M
Br J Cancer; 2015 Mar; 112(6):1067-75. PubMed ID: 25668006
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
[TBL] [Abstract][Full Text] [Related]
15. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.
Shi MF; Jiao J; Lu WG; Ye F; Ma D; Dong QG; Xie X
Cell Mol Life Sci; 2010 Nov; 67(22):3915-25. PubMed ID: 20549538
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer.
Yousefi M; Ghaffari P; Nosrati R; Dehghani S; Salmaninejad A; Abarghan YJ; Ghaffari SH
Cell Oncol (Dordr); 2020 Feb; 43(1):31-49. PubMed ID: 31828552
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
18. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
Hu Y; Li S; Yang M; Yan C; Fan D; Zhou Y; Zhang Y; Yagüe E; Xiong D
Breast Cancer Res Treat; 2014 Jan; 143(2):287-99. PubMed ID: 24337682
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
20. CD44
Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
